Inventor · disambiguated record
Ryan C. Clark
Also filed as: CLARK RYAN · CLARK RYAN C · CLARK RYAN CHRISTOPHER
18 granted patents·6 pending applications·82 citations·filing 2009–2023
92Inventor score
Files withNOVIRA THERAPEUTICS INC6MERCK PATENT GMBH4TEMPEST THERAPEUTICS INC4AMIRA PHARMACEUTICALS INC3CLARK RYAN2
Top patents by PatentIndex Score
24 records- 0196US9969710B2Heteroaryl compounds as IRAK inhibitors and uses thereofMERCK PATENT GMBH·Filed 2016·Granted May 15, 2018·41 cites·20 claims
- 0289US8664220B2Polycyclic compounds as lysophosphatidic acid receptor antagonistsCLARK RYAN·Filed 2010·Granted Mar 4, 2014·17 cites·4 claims
- 0384US8778983B2Polycyclic compounds as lysophosphatidic acid receptor antagonistsCLARK RYAN·Filed 2010·Granted Jul 15, 2014·7 cites·9 claims
- 0482US10160742B2Pyridyl reverse sulfonamides for HBV treatmentNOVIRA THERAPEUTICS INC·Filed 2017·Granted Dec 25, 2018·1 cites·8 claims
- 0579US2024041837A1Triazolone compounds and uses thereofTEMPEST THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0677US9597332B2Sulfide alkyl compounds for HBV treatmentNOVIRA THERAPEUTICS INC·Filed 2015·Granted Mar 21, 2017·1 cites·9 claims
- 0777US9090573B2Compounds as lysophosphatidic acid receptor antagonistsSEIDERS THOMAS J·Filed 2010·Granted Jul 28, 2015·6 cites·4 claims
- 0876US10196351B2Sulfide alkyl compounds for HBV treatmentNOVIRA THERAPEUTICS INC·Filed 2017·Granted Feb 5, 2019·1 cites·19 claims
- 0974US10568871B2Triazolone compounds and uses thereofTEMPEST THERAPEUTICS INC·Filed 2017·Granted Feb 25, 2020·1 cites·20 claims
- 1074US9676754B2Triazolone compounds and uses thereofINCEPTION 2 INC·Filed 2013·Granted Jun 13, 2017·2 cites·18 claims
- 1173US9765050B2Pyridyl reverse sulfonamides for HBV treatmentNOVIRA THERAPEUTICS INC·Filed 2015·Granted Sep 19, 2017·1 cites·9 claims
- 1271US10000456B2Polycyclic compounds as lysophosphatidic acid receptor antagonistsAMIRA PHARMACEUTICALS INC·Filed 2014·Granted Jun 19, 2018·1 cites·13 claims
- 1370US10710959B2Sulfide alkyl compounds for HBV treatmentNOVIRA THERAPEUTICS INC·Filed 2018·Granted Jul 14, 2020·0 cites·8 claims
- 1470US9624182B2Compounds as lysophosphatidic acid receptor antagonistsAMIRA PHARMACEUTICALS INC·Filed 2015·Granted Apr 18, 2017·1 cites·13 claims
- 1569US11666557B2Triazolone compounds and uses thereofTEMPEST THERAPEUTICS INC·Filed 2019·Granted Jun 6, 2023·0 cites·19 claims
- 1669US9505728B2Triazolone compounds and uses thereofINCEPTION 2 INC·Filed 2013·Granted Nov 29, 2016·2 cites·25 claims
- 1766US10428041B2Pyridyl reverse sulfonamides for HBV treatmentNOVIRA THERAPEUTICS INC·Filed 2018·Granted Oct 1, 2019·0 cites·20 claims
- 1854US2023234943A1Trex1 inhibitors and uses thereofTEMPEST THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1951US10392375B2Heteroaryl compounds as IRAK inhibitors and uses thereofMERCK PATENT GMBH·Filed 2018·Granted Aug 27, 2019·0 cites·11 claims
- 2050US2011112134A1Tricyclic Antagonists of Prostaglandin D2 ReceptorsAMIRA PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 2149US2018237413A1Heteroaryl compounds as irak inhibitors and uses thereofMERCK PATENT GMBH·Filed 2018·Application pending·0 cites
- 2246US10059701B2Heteroaryl compounds as IRAK inhibitors and uses thereofMERCK PATENT GMBH·Filed 2016·Granted Aug 28, 2018·0 cites·11 claims
- 2345US2021363152A1Aminoazine amidesHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 2433US2012004233A1Tricyclic compounds as antagonists of prostaglandin d2 receptorsSTEARNS BRIAN ANDREW·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ryan C. Clark files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →